A nano-silver bactericidal and hemostatic composition
A technology of nano-silver and composition, applied in the field of biomedicine, can solve the problems of shallow wound treatment, inability to stop bleeding and pain quickly, and poor biocompatibility.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
preparation example Construction
[0079] The third aspect of the present invention provides the preparation method of the nano-silver bactericidal and hemostatic composition, comprising the following steps:
[0080] (1) Add modified hyaluronic acid and ethacridine lactic acid into the reactor in parts by weight, then add water as a solvent, heat to 55°C-75°C to dissolve, stir evenly, and obtain liquid A;
[0081] (2) Processing liquid A in step (1) to obtain substance B;
[0082] (3) Add carboxymethyl chitosan grafted sodium polyacrylate and auxiliary agents to the substance B in step (2) in parts by weight, heat to 60° C. to 80° C., and stir evenly to obtain substance C;
[0083] (4) cooling and filtering the substance C in step (3) to obtain solid D;
[0084] (5) Sterilize the substance D in the step (4) to obtain a nano-silver bactericidal and hemostatic composition.
[0085] In one embodiment, the specific step of post-treatment described in step (2) is: add 0.5mL N-hydroxysuccinimide (0.06mol / L), 1-( 3...
Embodiment 1
[0096] Embodiment 1 of the present invention provides a nano-silver bactericidal and hemostatic composition, the preparation raw materials of the nano-silver bactericidal and hemostatic composition are calculated in parts by weight, and include the following components:
[0097] 30 parts of modified hyaluronic acid;
[0098] 3 parts of ethacridine lactate;
[0099] Carboxymethyl chitosan grafted sodium polyacrylate 5 parts;
[0100] Wherein, the modified hyaluronic acid includes organic components and inorganic components; the inorganic components include nano-silver and / or calcium ions;
[0101] The preparation method of described modified hyaluronic acid is:
[0102] (1) Under a nitrogen atmosphere, weigh 0.01mol of hyaluronic acid, 0.25mol of maleic anhydride, 0.3mol of 2,4-hexadienedioic acid and 0.26mol of 1,2,3,4-diepoxybutane for reaction Add 4.5mL of N,N-dimethylformamide and 0.001mol of tetrabutylammonium bromide to the bottle, heat in an oil bath at 90°C for 18h; ob...
Embodiment 2
[0126] Embodiment 2 of the present invention provides a nano-silver bactericidal and hemostatic composition, the preparation raw materials of the nano-silver bactericidal and hemostatic composition are calculated by weight, and include the following components:
[0127] 50 parts of modified hyaluronic acid;
[0128] 5 parts of ethacridine lactate;
[0129] 8 parts of carboxymethyl chitosan grafted sodium polyacrylate;
[0130] Wherein, the modified hyaluronic acid includes organic components and inorganic components; the inorganic components include nano-silver and / or calcium ions;
[0131] The preparation method of the modified hyaluronic acid is the same as in Example 1;
[0132] The ethacridine lactate CAS: 1837-57-6;
[0133] The preparation method of described carboxymethyl chitosan graft sodium polyacrylate is with embodiment 1;
[0134] The bactericidal and hemostatic combination also includes 3 to 8 parts of auxiliary agents, and the auxiliary agents include povido...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com